121 related articles for article (PubMed ID: 19851194)
1. Coexistant iodine-negative pleural metastasis with iodine-positive lung and bone metastases in a patient with differentiated thyroid cancer.
Qiu ZL; Luo QY
Clin Nucl Med; 2009 Nov; 34(11):836-7. PubMed ID: 19851194
[No Abstract] [Full Text] [Related]
2. [Distant metastasis of differentiated thyroid cancers. Diagnosis by 131 iodine (I 131) and treatment].
Leger AF
Ann Endocrinol (Paris); 1995; 56(3):205-8. PubMed ID: 7677405
[TBL] [Abstract][Full Text] [Related]
3. An aggressive radio-resistant papillary thyroid cancer.
Mehta RS; Negin B; Popii V; Langer C
Clin Adv Hematol Oncol; 2008 Oct; 6(10):761-7. PubMed ID: 18997667
[No Abstract] [Full Text] [Related]
4. Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid carcinoma.
Miyamoto S; Kasagi K; Misaki T; Alam MS; Konishi J
J Nucl Med; 1997 Mar; 38(3):352-6. PubMed ID: 9074516
[TBL] [Abstract][Full Text] [Related]
5. Role of initial iodine-131 whole-body scan and serum thyroglobulin in differentiated thyroid carcinoma metastases.
Filesi M; Signore A; Ventroni G; Melacrinis FF; Ronga G
J Nucl Med; 1998 Sep; 39(9):1542-6. PubMed ID: 9744339
[TBL] [Abstract][Full Text] [Related]
6. In follicular thyroid carcinoma we found,
Xiao L; Zhang WJ; Li L
Hell J Nucl Med; 2019; 22(2):140-141. PubMed ID: 31273357
[No Abstract] [Full Text] [Related]
7. I-131 whole body scintigraphy in a patient with micronodular pulmonary metastases from papillary thyroid carcinoma.
Ruíz Hernández G; Vázquez Forner C; Fliquete Peris MV
Nuklearmedizin; 2000; 39(1):40-1. PubMed ID: 10726257
[No Abstract] [Full Text] [Related]
8. Comparison of the therapeutic dose and diagnostic dose of 131I in the detection of metastatic foci of differentiated thyroid cancer.
Tung CC; Chang TC; Su CT; Chen FW; Chang CC
Taiwan Yi Xue Hui Za Zhi; 1988 Nov; 87(11):1081-5. PubMed ID: 3235967
[No Abstract] [Full Text] [Related]
9. [131I-accumulating pulmonary and bone metastases of differentiated thyroid cancer with low serum thyroglobulin levels--an exception in tumor follow-up?].
Arning G; Ehrenheim C; Schober O; Hundeshagen H
Nuklearmedizin; 1987 Jun; 26(3):139-42. PubMed ID: 3628022
[TBL] [Abstract][Full Text] [Related]
10. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.
Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY
J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315
[TBL] [Abstract][Full Text] [Related]
11. Bone metastasis from thyroid cancer diagnosed by I-131 whole-body scan without identifiable lesion in the thyroid.
Wang J; Liu B; Zhao Z; Kuang A
Clin Nucl Med; 2011 Nov; 36(11):1033-5. PubMed ID: 21975397
[No Abstract] [Full Text] [Related]
12. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
[TBL] [Abstract][Full Text] [Related]
13. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
14. Clinical trials for progressive differentiated thyroid cancer: patient selection, study design, and recent advances.
Schlumberger M; Sherman SI
Thyroid; 2009 Dec; 19(12):1393-400. PubMed ID: 20001721
[TBL] [Abstract][Full Text] [Related]
15. Bone scan appearance in aggressive osteogenic sarcoma with pleural, lung, bone, and soft-tissue metastases.
Othman S; El-Desouki M
Clin Nucl Med; 2003 Nov; 28(11):926. PubMed ID: 14578712
[TBL] [Abstract][Full Text] [Related]
16. [X-ray characteristics of thyroid cancer metastases into the organs of the chest cavity].
Lutsenko IV
Vestn Rentgenol Radiol; 1984; (1):33-8. PubMed ID: 6710846
[No Abstract] [Full Text] [Related]
17. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
[No Abstract] [Full Text] [Related]
18. [Management of metastasis. Medullary cancers excluded].
Chigot JP
Ann Endocrinol (Paris); 1997; 58(4):335-7. PubMed ID: 9436484
[TBL] [Abstract][Full Text] [Related]
19. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
20. Metastatic differentiated thyroid carcinoma: clinicopathological profile and outcome in an iodine deficient area.
Mishra A; Mishra SK; Agarwal A; Das BK; Agarwal G; Gambhir S
World J Surg; 2002 Feb; 26(2):153-7. PubMed ID: 11865341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
